We are currently in a period where it is as if the EU medtech regulations are being stirred round in a cauldron by three witches representing the EU institutions who must agree any new regulatory proposal.
EU Experts Vollebregt and Melvin Agree Over Nature Of Changes Needed To MDR
Harmonization through increased centralization was a key theme that ran through a recent discussion between Erik Vollebregt and Tom Melvin about the MDR. Both agreed that far-reaching short-term changes are not only possible but vital.
